# COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC

> **NCT02484664** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 12 (actual)

## Conditions studied

- Lymphangioleiomyomatosis (LAM)

## Interventions

- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT02484664
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-15
- **Primary completion:** 2018-11-19
- **Final completion:** 2018-11-19
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484664, "COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02484664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*